Tianrong Medical Group Inc. (OTC:TNMD) CEO Issues Letter to Shareholders

Okemos, Michigan Sep 8, 2025  – Tianrong Medical Group Inc. (OTC: TNMD) is spearheading a transformation in the real estate industry. The company’s CEO, Curtis L. Philpot, recently informed shareholders via a letter that the company has achieved a significant milestone with the acquisition of Pillar Properties Inc. This Michigan-based real estate holdings firm will establish a foundational portfolio through subsequent acquisitions. In the letter, the CEO articulated the company’s intent to develop one of the most innovative ventures in the real estate sector: the eventual creation of a tokenized Real Estate Investment Trust (REIT).

According to the CEO’s communication, this acquisition represents more than a mere expansion of assets. It serves as the cornerstone for a vision to fundamentally redefine real estate ownership, accessibility, and investment. The company is poised to harness the power of tokenization, aiming to merge the enduring strength of real estate with the efficiency and accessibility afforded by blockchain technology. Its long-term strategy involves democratizing real estate investment for a broader spectrum of investors while ensuring sustainable value for shareholders. Through tokenization, the company is actively shaping the future of real estate.

Real estate has long been recognized as a proven asset class. However, public access has historically been constrained by substantial capital requirements, inherent illiquidity, and geographic limitations. Mr. Philpot’s letter highlights tokenization as a strategic solution to these barriers. This process converts the ownership rights of physical properties into secure digital tokens, which are immutably recorded on a blockchain. This mechanism will enable fractional ownership, allowing investors of all sizes to participate in high-value properties, and enhance liquidity, as these tokens can be traded on compliant platforms. Furthermore, blockchain’s provision of immutable records for ownership and transactions will ensure transparency, alongside bringing heightened efficiency and global reach to the company.

Curtis L. Philpot emphasizes in his shareholder letter that this envisioned future is not a distant concept. By seamlessly integrating traditional real estate with blockchain innovation, Tianrong Medical Group Inc. is strategically positioning itself to lead in the forthcoming era of financial and real estate transformation. The company’s strategic focus encompasses five core sectors: Residential Housing, Commercial Assets, Development Projects, Senior Living and Healthcare, and Telecom Infrastructure. The CEO further notes in his letter that the company will soon unveil its initial acquisition, marking the commencement of a portfolio designed to form the bedrock of this vision. Each asset brought into the company’s holdings is meticulously selected to bolster both near-term cash flows and long-term shareholder value. He further assures that, once launched, the company’s tokenized REIT will stand as a benchmark for transparency, innovation, and accessibility.

In his letter, Mr. Philpot also requested the continued trust and support of the company’s shareholders, underscoring their vital role in this mission. With the acquisition of Pillar Properties and its clear trajectory toward a tokenized REIT, Tianrong Medical Group Inc. (OTC: TNMD) is strategically positioned to generate sustainable, long-term value for all stakeholders.

To learn more, visit 

This press release (or shareholder communication) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, and, as such, are subject to risks and uncertainties. Forward-looking statements are founded on current expectations, estimates, and projections regarding the business of Tianrong Medical Group Inc. (OTC: TNMD) and are characterized by terms such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “may,” “will,” “should,” and similar expressions.

These forward-looking statements do not guarantee future performance and are subject to risks, uncertainties, and assumptions that are inherently difficult to predict. Actual results could materially differ from those projected or implied in such forward-looking statements due to various factors, including, but not limited to: general economic conditions, shifts in real estate and financial markets, regulatory developments, the adoption rate of blockchain technology, availability of capital, competitive pressures, and other risks and uncertainties detailed in the company’s filings with OTC Markets and/or the Securities and Exchange Commission (SEC), as applicable.

Investors are advised against placing undue reliance on these forward-looking statements, which are valid only as of their respective dates. Unless mandated by applicable law, Tianrong Medical Group Inc. (OTC: TNMD) disclaims any obligation to publicly update or revise any forward-looking statements, whether due to new information, future events, or any other circumstances.